ZYMEZymeworks Inc.

$25.80+59% 1Y

What is the market doing?

Mixed

No clear lean: rangebound and moderately shorted.

2 neutral, 1 without data
TrendRangeboundderived · Oct 9, 2026

Choppy, but holding above its 200-day average. Price is +3% vs its 200-day average.

Short interest6.6% of sharesFINRA · Sep 15, 2026

Moderately shorted, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

1-year returnbetter than 85% of the market
vs 200-day avgmiddle of the market

Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.

How ZYME is trading

Zymeworks Inc. is +59% over the past year while the S&P 500 is +18%: 40 points ahead of the market.

+59%

1-year return · S&P 500 +18%

vs 200-day average
+2.6%

vs 200-day average · close to trend

RSI (14)
44

RSI (14) · neutral

Below its 52-week high
17%

Below its 52-week high

Sep 18, 2024$9.44 – $31.05 · dashed line: 200-day averageOct 9, 2026
Details›
Last close2026-10-09
$25.80
1 monthS&P 500 +2.7%
−2.4%
1 yearS&P 500 +18%
+59%
5 yearsS&P 500 +88%
−22%
vs 50-day average$26.38
−2.2%
52-week high
$31.05
52-week low
$16.16
Annualised volatility
53%
Calendar-year price return
YearReturn
2026 (year to date)−2.0%
2025+80%
2024+41%
2023+32%
2022−52%
2021−65%
2020+4.0%
2019+210%
2018+93%
Average return by calendar month, 2017–2026
MonthYearsPositiveAverage
Jan94 of 9+1.5%
Feb93 of 9−5.7%
Mar94 of 9−2.1%
Apr96 of 9+4.6%
May103 of 10+0.74%
Jun105 of 10−4.7%
Jul104 of 10−3.3%
Aug109 of 10+12%
Sep104 of 10+2.5%
Oct106 of 10+3.6%
Nov97 of 9+14%
Dec95 of 9+0.49%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.